Gut hormones and appetite regulation
- PMID: 38511400
- DOI: 10.1097/MED.0000000000000859
Gut hormones and appetite regulation
Abstract
Purpose of review: Various gut hormones interact with the brain through delicate communication, thereby influencing appetite and subsequent changes in body weight. This review summarizes the effects of gut hormones on appetite, with a focus on recent research.
Recent findings: Ghrelin is known as an orexigenic hormone, whereas glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), cholecystokinin (CCK), postprandial peptide YY (PYY), and oxyntomodulin (OXM) are known as anorexigenic hormones. Recent human studies have revealed that gut hormones act differently in various systems, including adipose tissue, beyond appetite and energy intake, and even involve in high-order thinking. Environmental factors including meal schedule, food contents and quality, type of exercise, and sleep deprivation also play a role in the influence of gut hormone on appetite, weight change, and obesity. Recently published studies have shown that retatrutide, a triple-agonist of GLP-1, GIP, and glucagon receptor, and orforglipron, a GLP-1 receptor partial agonist, are effective in weight loss and improving various metabolic parameters associated with obesity.
Summary: Various gut hormones influence appetite, and several drugs targeting these receptors have been reported to exert positive effects on weight loss in humans. Given that diverse dietary and environmental factors affect the actions of gut hormones and appetite, there is a need for integrated and largescale long-term studies in this field.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Weltens N, Iven J, Van Oudenhove L, et al. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci 2018; 1428:129–150.
-
- Berthoud H-R, Albaugh VL, Neuhuber WL. Gut-brain communication and obesity: understanding functions of the vagus nerve. J Clin Invest 2021; 131:143770.
-
- Roh E, Choi KM. Hormonal gut-brain signaling for the treatment of obesity. Int J Mol Sci 2023; 24:3384.
-
- Aukan MI, Coutinho S, Pedersen SA, et al. Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity: a systematic review and meta-analysis. Obes Rev 2023; 24:e13531.
-
- Richards P, Thornberry NA, Pinto S. The gut-brain axis: identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders. Mol Metab 2021; 46:101175.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
